Use of d4 and 5-ht2a antagonists, inverse agonists or...

A - Human Necessities – 61 – K

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

A61K 31/4545 (2006.01) A61K 31/165 (2006.01) A61K 31/198 (2006.01) A61K 31/519 (2006.01) A61K 31/55 (2006.01) A61P 25/00 (2006.01) A61P 25/28 (2006.01)

Patent

CA 2547639

The present invention relates to the use of compounds and compositions of compounds having D4 and 5-HT2A antagonistic, partial agonistic or inverse agonistic activity for the treatment of the underlying dysregulation of the emotional functionality of mental disorders (i.e. affect instability - hypersensitivity - hyperaesthesia - dissociative phenomena - etc). The invention also relates to methods comprising administering to a patient diagnosed as having a neuropsychiatric disorder a pharmaceutical composition containing (i) compounds having D4 antagonistic, partial agonistic or inverse agonistic activity and (ii) compounds having 5-HT2A antagonistic, partial agonistic or inverse agonistic, and (iii) any known medicinal compound and compositions of said compounds. The combined D4 and 5-HT2A antagonistic, partial agonistic or inverse agonistic effects may reside within the same chemical or biological compound or in two different chemical and/or biological compounds.

La présente invention a trait à des composés et des compositions de composés présentant une activité antagoniste, agoniste partielle ou agoniste inverse de D4 et de 5HT2A pour le traitement de la dérégulation sous-jacente de la fonctionnalité émotionnelle de troubles mentaux (c'est à dire, l'instabilité affective, l'hypersensibilité, l'hyperesthésie, le phénomène dissociatif, et autres). L'invention a également trait à des procédés comprenant l'administration à un patient diagnostiqué comme atteint d'un trouble neuropsychiatrique d'une composition pharmaceutique contenant (i) des composés présentant une activité antagoniste, agoniste partielle ou agoniste inverse de D4 et (ii) des composés présentant une activité antagoniste, agoniste partielle ou agoniste inverse, et (iii) tout composé et toute composition médicinal(e) connu (e) desdits composés. Les effets antagoniste, agoniste partiel ou antagoniste inverse peuvent se trouver dans le même composé chimique ou biologique ou dans deux composés chimiques et/ou biologiques différents.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Use of d4 and 5-ht2a antagonists, inverse agonists or... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Use of d4 and 5-ht2a antagonists, inverse agonists or..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of d4 and 5-ht2a antagonists, inverse agonists or... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1902673

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.